Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 Oct;107(Suppl 5):701–707. doi: 10.1289/ehp.99107s5701

Neuroendocrine host factors and inflammatory disease susceptibility.

S Ligier 1, E M Sternberg 1
PMCID: PMC1566252  PMID: 10502534

Abstract

The etiology of autoimmune diseases is multifactorial, resulting from a combination of genetically predetermined host characteristics and environmental exposures. As the term autoimmune implies, immune dysfunction and dysregulated self-tolerance are key elements in the pathophysiology of all these diseases. The neuroendocrine and sympathetic nervous systems are increasingly recognized as modulators of the immune response at the levels of both early inflammation and specific immunity. As such, alterations in their response represent a potential mechanism by which pathologic autoimmunity may develop. Animal models of autoimmune diseases show pre-existing changes in neuroendocrine responses to a variety of stimuli, and both animal and human studies have shown altered stress responses in the setting of active immune activation. The potential role of the neuroendocrine system in linking environmental exposures and autoimmune diseases is 2-fold. First, it may represent a direct target for toxic compounds. Second, its inadequate function may result in the inappropriate response of the immune system to an environmental agent with immunogenic properties. This article reviews the relationship between autoimmune diseases and the neuroendocrine system and discusses the difficulties and pitfalls of investigating a physiologic response that is sensitive to such a multiplicity of environmental exposures.

Full text

PDF
701

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelson J. L., Curtis G. C. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels. Am J Psychiatry. 1996 Jan;153(1):69–73. doi: 10.1176/ajp.153.1.69. [DOI] [PubMed] [Google Scholar]
  2. Adinoff B., Martin P. R., Bone G. H., Eckardt M. J., Roehrich L., George D. T., Moss H. B., Eskay R., Linnoila M., Gold P. W. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry. 1990 Apr;47(4):325–330. doi: 10.1001/archpsyc.1990.01810160025004. [DOI] [PubMed] [Google Scholar]
  3. Aguilera G., Jessop D. S., Harbuz M. S., Kiss A., Lightman S. L. Differential regulation of hypothalamic pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat. J Endocrinol. 1997 May;153(2):185–191. doi: 10.1677/joe.0.1530185. [DOI] [PubMed] [Google Scholar]
  4. Alvarez-Nemegyei J., Cobarrubias-Cobos A., Escalante-Triay F., Sosa-Muñoz J., Miranda J. M., Jara L. J. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus. 1998;7(6):414–419. doi: 10.1191/096120398678920334. [DOI] [PubMed] [Google Scholar]
  5. Bagchi N., Brown T. R., Urdanivia E., Sundick R. S. Induction of autoimmune thyroiditis in chickens by dietary iodine. Science. 1985 Oct 18;230(4723):325–327. doi: 10.1126/science.4048936. [DOI] [PubMed] [Google Scholar]
  6. Banks W. A., Kastin A. J. Relative contributions of peripheral and central sources to levels of IL-1 alpha in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays. J Neuroimmunol. 1997 Oct;79(1):22–28. doi: 10.1016/s0165-5728(97)00103-3. [DOI] [PubMed] [Google Scholar]
  7. Becker K. G., Simon R. M., Bailey-Wilson J. E., Freidlin B., Biddison W. E., McFarland H. F., Trent J. M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9979–9984. doi: 10.1073/pnas.95.17.9979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bluthé R. M., Walter V., Parnet P., Layé S., Lestage J., Verrier D., Poole S., Stenning B. E., Kelley K. W., Dantzer R. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III. 1994 Jun;317(6):499–503. [PubMed] [Google Scholar]
  9. Brennan F. M., Maini R. N., Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull. 1995 Apr;51(2):368–384. doi: 10.1093/oxfordjournals.bmb.a072967. [DOI] [PubMed] [Google Scholar]
  10. Brezinschek H. P., Gruschwitz M., Sgonc R., Moormann S., Herold M., Gershwin M. E., Wick G. Effects of cytokine application on glucocorticoid secretion in an animal model for systemic scleroderma. J Autoimmun. 1993 Dec;6(6):719–733. doi: 10.1006/jaut.1993.1060. [DOI] [PubMed] [Google Scholar]
  11. Chikanza I. C., Petrou P., Kingsley G., Chrousos G., Panayi G. S. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 1992 Nov;35(11):1281–1288. doi: 10.1002/art.1780351107. [DOI] [PubMed] [Google Scholar]
  12. Chrousos G. P., Gold P. W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992 Mar 4;267(9):1244–1252. [PubMed] [Google Scholar]
  13. Chrousos G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995 May 18;332(20):1351–1362. doi: 10.1056/NEJM199505183322008. [DOI] [PubMed] [Google Scholar]
  14. Crofford L. J., Kalogeras K. T., Mastorakos G., Magiakou M. A., Wells J., Kanik K. S., Gold P. W., Chrousos G. P., Wilder R. L. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 1997 Apr;82(4):1279–1283. doi: 10.1210/jcem.82.4.3852. [DOI] [PubMed] [Google Scholar]
  15. Crofford L. J., Rader J. I., Dalakas M. C., Hill R. H., Jr, Page S. W., Needham L. L., Brady L. S., Heyes M. P., Wilder R. L., Gold P. W. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest. 1990 Nov;86(5):1757–1763. doi: 10.1172/JCI114902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Davis D. L., Axelrod D., Bailey L., Gaynor M., Sasco A. J. Rethinking breast cancer risk and the environment: the case for the precautionary principle. Environ Health Perspect. 1998 Sep;106(9):523–529. doi: 10.1289/ehp.98106523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. DeRijk R. H., Petrides J., Deuster P., Gold P. W., Sternberg E. M. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J Clin Endocrinol Metab. 1996 Jan;81(1):228–235. doi: 10.1210/jcem.81.1.8550757. [DOI] [PubMed] [Google Scholar]
  18. DeRijk R., Michelson D., Karp B., Petrides J., Galliven E., Deuster P., Paciotti G., Gold P. W., Sternberg E. M. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab. 1997 Jul;82(7):2182–2191. doi: 10.1210/jcem.82.7.4041. [DOI] [PubMed] [Google Scholar]
  19. Dorn L. D., Burgess E. S., Susman E. J., von Eye A., DeBellis M. D., Gold P. W., Chrousos G. P. Response to oCRH in depressed and nondepressed adolescents: does gender make a difference? J Am Acad Child Adolesc Psychiatry. 1996 Jun;35(6):764–773. doi: 10.1097/00004583-199606000-00016. [DOI] [PubMed] [Google Scholar]
  20. Ehlert U., Straub R. Physiological and emotional response to psychological stressors in psychiatric and psychosomatic disorders. Ann N Y Acad Sci. 1998 Jun 30;851:477–486. doi: 10.1111/j.1749-6632.1998.tb09026.x. [DOI] [PubMed] [Google Scholar]
  21. Elbourne K. B., Keisler D., McMurray R. W. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus. 1998;7(6):420–427. doi: 10.1191/096120398678920352. [DOI] [PubMed] [Google Scholar]
  22. Elenkov I. J., Papanicolaou D. A., Wilder R. L., Chrousos G. P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians. 1996 Sep;108(5):374–381. [PubMed] [Google Scholar]
  23. Emslie-Smith A. M., Mayeno A. N., Nakano S., Gleich G. J., Engel A. G. 1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome. Neurology. 1994 Dec;44(12):2390–2392. doi: 10.1212/wnl.44.12.2390. [DOI] [PubMed] [Google Scholar]
  24. Flower R. J., Parente L., Persico P., Salmon J. A. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br J Pharmacol. 1986 Jan;87(1):57–62. doi: 10.1111/j.1476-5381.1986.tb10156.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Folomeev M., Dougados M., Beaune J., Kouyoumdjian J. C., Nahoul K., Amor B., Alekberova Z. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus. 1992 May;1(3):191–195. doi: 10.1177/096120339200100312. [DOI] [PubMed] [Google Scholar]
  26. Fässler R., Dietrich H., Krömer G., Schwarz S., Brezinschek H. P., Wick G. Diminished glucocorticoid tonus in obese strain (OS) chickens with spontaneous autoimmune thyroiditis: increased plasma levels of a physicochemically unaltered corticosteroid-binding globulin but normal total corticosterone plasma concentration and normal glucocorticoid receptor contents in lymphoid tissues. J Steroid Biochem. 1988;30(1-6):375–379. doi: 10.1016/0022-4731(88)90126-4. [DOI] [PubMed] [Google Scholar]
  27. Green P. G., Jänig W., Levine J. D. Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci. 1997 May 1;17(9):3234–3238. doi: 10.1523/JNEUROSCI.17-09-03234.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Green P. G., Miao F. J., Strausbaugh H., Heller P., Janig W., Levine J. D. Endocrine and vagal controls of sympathetically dependent neurogenic inflammation. Ann N Y Acad Sci. 1998 May 1;840:282–288. doi: 10.1111/j.1749-6632.1998.tb09568.x. [DOI] [PubMed] [Google Scholar]
  29. Gutiérrez M. A., Garcia M. E., Rodriguez J. A., Rivero S., Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus. 1998;7(6):404–408. doi: 10.1191/096120398678920343. [DOI] [PubMed] [Google Scholar]
  30. Hall J., Morand E. F., Medbak S., Zaman M., Perry L., Goulding N. J., Maddison P. J., O'Hare J. P. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum. 1994 Aug;37(8):1132–1137. doi: 10.1002/art.1780370804. [DOI] [PubMed] [Google Scholar]
  31. Harbuz M. S., Conde G. L., Marti O., Lightman S. L., Jessop D. S. The hypothalamic-pituitary-adrenal axis in autoimmunity. Ann N Y Acad Sci. 1997 Aug 14;823:214–224. doi: 10.1111/j.1749-6632.1997.tb48393.x. [DOI] [PubMed] [Google Scholar]
  32. Harbuz M. S., Rees R. G., Eckland D., Jessop D. S., Brewerton D., Lightman S. L. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology. 1992 Mar;130(3):1394–1400. doi: 10.1210/endo.130.3.1537299. [DOI] [PubMed] [Google Scholar]
  33. Harkness J. A., Richter M. B., Panayi G. S., Van de Pette K., Unger A., Pownall R., Geddawi M. Circadian variation in disease activity in rheumatoid arthritis. Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):551–554. doi: 10.1136/bmj.284.6315.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Herold M., Brezinschek H. P., Gruschwitz M., Dietrich H., Wick G. Investigation of ACTH responses of chickens with autoimmune disease. Gen Comp Endocrinol. 1992 Nov;88(2):188–198. doi: 10.1016/0016-6480(92)90250-n. [DOI] [PubMed] [Google Scholar]
  35. Johnson E. O., Vlachoyiannopoulos P. G., Skopouli F. N., Tzioufas A. G., Moutsopoulos H. M. Hypofunction of the stress axis in Sjögren's syndrome. J Rheumatol. 1998 Aug;25(8):1508–1514. [PubMed] [Google Scholar]
  36. Jorgensen C., Bressot N., Bologna C., Sany J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol. 1995 Oct;22(10):1829–1833. [PubMed] [Google Scholar]
  37. Järvinen P., Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum. 1994 Aug;24(1):19–28. doi: 10.1016/0049-0172(94)90096-5. [DOI] [PubMed] [Google Scholar]
  38. Kanik K. S., Hagiwara E., Yarboro C. H., Schumacher H. R., Wilder R. L., Klinman D. M. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol. 1998 Jan;25(1):16–22. [PubMed] [Google Scholar]
  39. Karalis K., Crofford L., Wilder R. L., Chrousos G. P. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology. 1995 Jul;136(7):3107–3112. doi: 10.1210/endo.136.7.7789338. [DOI] [PubMed] [Google Scholar]
  40. Karanth S., Lyson K., McCann S. M. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3383–3387. doi: 10.1073/pnas.90.8.3383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kavelaars A., de Jong-de Vos van Steenwijk T., Kuis W., Heijnen C. J. The reactivity of the cardiovascular system and immunomodulation by catecholamines in juvenile chronic arthritis. Ann N Y Acad Sci. 1998 May 1;840:698–704. doi: 10.1111/j.1749-6632.1998.tb09608.x. [DOI] [PubMed] [Google Scholar]
  42. Kirwan J. R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med. 1995 Jul 20;333(3):142–146. doi: 10.1056/NEJM199507203330302. [DOI] [PubMed] [Google Scholar]
  43. Lechner O., Hu Y., Jafarian-Tehrani M., Dietrich H., Schwarz S., Herold M., Haour F., Wick G. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav Immun. 1996 Dec;10(4):337–350. doi: 10.1006/brbi.1996.0030. [DOI] [PubMed] [Google Scholar]
  44. Li H. Y., Ericsson A., Sawchenko P. E. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2359–2364. doi: 10.1073/pnas.93.6.2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Listwak S., Barrientos R. M., Koike G., Ghosh S., Gomez M., Misiewicz B., Sternberg E. M. Identification of a novel inflammation-protective locus in the Fischer rat. Mamm Genome. 1999 Apr;10(4):362–365. doi: 10.1007/s003359901002. [DOI] [PubMed] [Google Scholar]
  46. MacPhee I. A., Antoni F. A., Mason D. W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med. 1989 Feb 1;169(2):431–445. doi: 10.1084/jem.169.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Madden K. S., Felten S. Y., Felten D. L., Hardy C. A., Livnat S. Sympathetic nervous system modulation of the immune system. II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J Neuroimmunol. 1994 Jan;49(1-2):67–75. doi: 10.1016/0165-5728(94)90182-1. [DOI] [PubMed] [Google Scholar]
  48. Madden K. S., Moynihan J. A., Brenner G. J., Felten S. Y., Felten D. L., Livnat S. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol. 1994 Jan;49(1-2):77–87. doi: 10.1016/0165-5728(94)90183-x. [DOI] [PubMed] [Google Scholar]
  49. Madden K. S., Thyagarajan S., Felten D. L. Alterations in sympathetic noradrenergic innervation in lymphoid organs with age. Ann N Y Acad Sci. 1998 May 1;840:262–268. doi: 10.1111/j.1749-6632.1998.tb09566.x. [DOI] [PubMed] [Google Scholar]
  50. Makino S., Smith M. A., Gold P. W. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology. 1995 Aug;136(8):3299–3309. doi: 10.1210/endo.136.8.7628364. [DOI] [PubMed] [Google Scholar]
  51. Masi A. T., Chrousos G. P. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol. 1996 Apr;23(4):577–581. [PubMed] [Google Scholar]
  52. McEwen B. S., Biron C. A., Brunson K. W., Bulloch K., Chambers W. H., Dhabhar F. S., Goldfarb R. H., Kitson R. P., Miller A. H., Spencer R. L. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev. 1997 Feb;23(1-2):79–133. doi: 10.1016/s0165-0173(96)00012-4. [DOI] [PubMed] [Google Scholar]
  53. McMurray R. W., Weidensaul D., Allen S. H., Walker S. E. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol. 1995 Nov;22(11):2084–2091. [PubMed] [Google Scholar]
  54. Michelson D., Stone L., Galliven E., Magiakou M. A., Chrousos G. P., Sternberg E. M., Gold P. W. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab. 1994 Sep;79(3):848–853. doi: 10.1210/jcem.79.3.8077372. [DOI] [PubMed] [Google Scholar]
  55. Miller S. C., Rapier S. H., Holtsclaw L. I., Turner B. B. Effects of psychological stress on joint inflammation and adrenal function during induction of arthritis in the Lewis rat. Neuroimmunomodulation. 1995 Nov-Dec;2(6):329–338. doi: 10.1159/000097212. [DOI] [PubMed] [Google Scholar]
  56. Misiewicz B., Poltorak M., Raybourne R. B., Gomez M., Listwak S., Sternberg E. M. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation. Exp Neurol. 1997 Aug;146(2):305–314. doi: 10.1006/exnr.1997.6446. [DOI] [PubMed] [Google Scholar]
  57. Misiewicz B., Zelazowska E., Raybourne R. B., Cizza G., Sternberg E. M. Inflammatory responses to carrageenan injection in LEW/N and F344/N rats: LEW/N rats show sex- and age-dependent changes in inflammatory reactions. Neuroimmunomodulation. 1996 Mar-Jun;3(2-3):93–101. doi: 10.1159/000097233. [DOI] [PubMed] [Google Scholar]
  58. Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996 Mar;17(3):138–146. doi: 10.1016/0167-5699(96)80606-2. [DOI] [PubMed] [Google Scholar]
  59. Neidhart M. Prolactin in autoimmune diseases. Proc Soc Exp Biol Med. 1998 Apr;217(4):408–419. doi: 10.3181/00379727-217-44251. [DOI] [PubMed] [Google Scholar]
  60. Pacak K., Palkovits M., Yadid G., Kvetnansky R., Kopin I. J., Goldstein D. S. Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am J Physiol. 1998 Oct;275(4 Pt 2):R1247–R1255. doi: 10.1152/ajpregu.1998.275.4.R1247. [DOI] [PubMed] [Google Scholar]
  61. Pal S. B. The secretion rate of cortisol in patients with rheumatoid arthritis. Clin Chim Acta. 1970 Jul;29(1):129–137. doi: 10.1016/0009-8981(70)90233-0. [DOI] [PubMed] [Google Scholar]
  62. Raskind M. A., Peskind E. R., Wilkinson C. W. Hypothalamic-pituitary-adrenal axis regulation and human aging. Ann N Y Acad Sci. 1994 Nov 30;746:327–335. doi: 10.1111/j.1749-6632.1994.tb39251.x. [DOI] [PubMed] [Google Scholar]
  63. Reber P. M. Prolactin and immunomodulation. Am J Med. 1993 Dec;95(6):637–644. doi: 10.1016/0002-9343(93)90360-2. [DOI] [PubMed] [Google Scholar]
  64. Reder A. T., Thapar M., Jensen M. A. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology. 1994 Dec;44(12):2289–2294. doi: 10.1212/wnl.44.12.2289. [DOI] [PubMed] [Google Scholar]
  65. Remmers E. F., Longman R. E., Du Y., O'Hare A., Cannon G. W., Griffiths M. M., Wilder R. L. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet. 1996 Sep;14(1):82–85. doi: 10.1038/ng0996-82. [DOI] [PubMed] [Google Scholar]
  66. Reveille J. D. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol. 1998 May;10(3):187–200. doi: 10.1097/00002281-199805000-00007. [DOI] [PubMed] [Google Scholar]
  67. Rovenský J., Juránková E., Rauová L., Blazícková S., Lukác J., Veselková Z., Jezová D., Vigas M. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol. 1997 Dec;24(12):2330–2334. [PubMed] [Google Scholar]
  68. SUGAR M. Arthritis and panhypopituitarism. J Clin Endocrinol Metab. 1953 Sep;13(9):1118–1121. doi: 10.1210/jcem-13-9-1118. [DOI] [PubMed] [Google Scholar]
  69. Sakabe K., Onoe M., Yoshida T., Furuya H., Kayama F., Chan E. K. Environmental estrogens increase expression of SS-A/Ro autoantigen in normal human epidermal keratinocytes. J Dermatol. 1998 Aug;25(8):558–560. doi: 10.1111/j.1346-8138.1998.tb02457.x. [DOI] [PubMed] [Google Scholar]
  70. Sakabe K., Yoshida T., Furuya H., Kayama F., Chan E. K. Estrogenic xenobiotics increase expression of SS-A/Ro autoantigens in cultured human epidermal cells. Acta Derm Venereol. 1998 Nov;78(6):420–423. doi: 10.1080/000155598442692. [DOI] [PubMed] [Google Scholar]
  71. Saldanha C., Tougas G., Grace E. Evidence for anti-inflammatory effect of normal circulating plasma cortisol. Clin Exp Rheumatol. 1986 Oct-Dec;4(4):365–366. [PubMed] [Google Scholar]
  72. Sawchenko P. E., Brown E. R., Chan R. K., Ericsson A., Li H. Y., Roland B. L., Kovács K. J. The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res. 1996;107:201–222. doi: 10.1016/s0079-6123(08)61866-x. [DOI] [PubMed] [Google Scholar]
  73. Schlaghecke R., Beuscher D., Kornely E., Specker C. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum. 1994 Aug;37(8):1127–1131. doi: 10.1002/art.1780370803. [DOI] [PubMed] [Google Scholar]
  74. Schlaghecke R., Kornely E., Wollenhaupt J., Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 1992 Jul;35(7):740–744. doi: 10.1002/art.1780350704. [DOI] [PubMed] [Google Scholar]
  75. Shanks N., Harbuz M. S., Jessop D. S., Perks P., Moore P. M., Lightman S. L. Inflammatory disease as chronic stress. Ann N Y Acad Sci. 1998 May 1;840:599–607. doi: 10.1111/j.1749-6632.1998.tb09599.x. [DOI] [PubMed] [Google Scholar]
  76. Silver R. M., Heyes M. P., Maize J. C., Quearry B., Vionnet-Fuasset M., Sternberg E. M. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med. 1990 Mar 29;322(13):874–881. doi: 10.1056/NEJM199003293221302. [DOI] [PubMed] [Google Scholar]
  77. Stenzel-Poore M., Vale W. W., Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 1993 Mar;132(3):1313–1318. doi: 10.1210/endo.132.3.8382598. [DOI] [PubMed] [Google Scholar]
  78. Sternberg E. M., Chrousos G. P., Wilder R. L., Gold P. W. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992 Nov 15;117(10):854–866. doi: 10.7326/0003-4819-117-10-854. [DOI] [PubMed] [Google Scholar]
  79. Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2374–2378. doi: 10.1073/pnas.86.7.2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Sternberg E. M. Neural-immune interactions in health and disease. J Clin Invest. 1997 Dec 1;100(11):2641–2647. doi: 10.1172/JCI119807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Sternberg E. M., Young W. S., 3rd, Bernardini R., Calogero A. E., Chrousos G. P., Gold P. W., Wilder R. L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4771–4775. doi: 10.1073/pnas.86.12.4771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Swain M. G., Maric M. Prevention of immune-mediated arthritis in cholestatic rats: involvement of endogenous glucocorticoids. Gastroenterology. 1994 Nov;107(5):1469–1474. doi: 10.1016/0016-5085(94)90551-7. [DOI] [PubMed] [Google Scholar]
  83. Templ E., Koeller M., Riedl M., Wagner O., Graninger W., Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol. 1996 Apr;35(4):350–356. doi: 10.1093/rheumatology/35.4.350. [DOI] [PubMed] [Google Scholar]
  84. ThyagaRajan S., Felten S. Y., Felten D. L. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of L-deprenyl treatment in young sympathectomized and old Fischer 344 rats. J Neuroimmunol. 1998 Jan;81(1-2):144–157. doi: 10.1016/s0165-5728(97)00169-0. [DOI] [PubMed] [Google Scholar]
  85. Van de Water J., Jimenez S. A., Gershwin M. E. Animal models of scleroderma: contrasts and comparisons. Int Rev Immunol. 1995;12(2-4):201–216. doi: 10.3109/08830189509056713. [DOI] [PubMed] [Google Scholar]
  86. Vilarinho S. T., Costallat L. T. Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus. J Rheumatol. 1998 Jun;25(6):1097–1103. [PubMed] [Google Scholar]
  87. Walker S. E., McMurray R. W., Houri J. M., Allen S. H., Keisler D., Sharp G. C., Schlechte J. A. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci. 1998 May 1;840:762–772. doi: 10.1111/j.1749-6632.1998.tb09615.x. [DOI] [PubMed] [Google Scholar]
  88. Watkins L. R., Goehler L. E., Relton J. K., Tartaglia N., Silbert L., Martin D., Maier S. F. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett. 1995 Jan 2;183(1-2):27–31. doi: 10.1016/0304-3940(94)11105-r. [DOI] [PubMed] [Google Scholar]
  89. Webster E. L., Torpy D. J., Elenkov I. J., Chrousos G. P. Corticotropin-releasing hormone and inflammation. Ann N Y Acad Sci. 1998 May 1;840:21–32. doi: 10.1111/j.1749-6632.1998.tb09545.x. [DOI] [PubMed] [Google Scholar]
  90. Wick G., Sgonc R., Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann N Y Acad Sci. 1998 May 1;840:591–598. doi: 10.1111/j.1749-6632.1998.tb09598.x. [DOI] [PubMed] [Google Scholar]
  91. Wilder R. L., Allen J. B., Hansen C. Thymus-dependent and -independent regulation of Ia antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis. Differences in site and intensity of expression in euthymic, athymic, and cyclosporin A-treated LEW and F344 rats. J Clin Invest. 1987 Apr;79(4):1160–1171. doi: 10.1172/JCI112933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Wilder R. L. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci. 1998 May 1;840:45–50. doi: 10.1111/j.1749-6632.1998.tb09547.x. [DOI] [PubMed] [Google Scholar]
  93. Yanovski J. A., Yanovski S. Z., Harrington L., Gold P. W., Chrousos G. P. Differences in the hypothalamic-pituitary-adrenal axis of black and white men. Horm Res. 1995;44(5):208–212. doi: 10.1159/000184627. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES